Pre-aggregated Aβ1-42 peptide increases tau aggregation and hyperphosphorylation after short-term application (Q39626472)

13 September 2017

Pre-aggregated Aβ1-42 peptide increases tau aggregation and hyperphosphorylation after short-term application (English)

1 reference

13 September 2017

5

1 reference

13 September 2017

Jens Wiltfang

6

0 references

Andreas Wolfram Henkel

series ordinal

2

object named as

Andreas Wolfram Henkel

1 reference

13 September 2017

3

Maria Kerstin Henkel

1 reference

13 September 2017

Sabine Ott

1

1 reference

PubMed ID

21113648

13 September 2017

Zoran B Redzic

series ordinal

4

1 reference

PubMed ID

21113648

13 September 2017

language of work or name

1 reference

27 November 2010

1 reference

Molecular and Cellular Biochemistry

13 September 2017

1 reference

13 September 2017

349

1 reference

13 September 2017

1-2

1 reference

13 September 2017

169-177

1 reference

https://scigraph.springernature.com/pub.10.1007/s11010-010-0671-7

13 September 2017

0 references

cites work

The molecular pathology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

REVIEW: tau protein pathology in Alzheimer's disease and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Alzheimer disease: current concepts and emerging diagnostic and therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Expression of the APP gene family in brain cells, brain development and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Amyloid deposition as the central event in the aetiology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Paired Helical Filaments in Electron Microscopy of Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Phosphorylation of Ser262 strongly reduces binding of tau to microtubules: distinction between PHF-like immunoreactivity and microtubule binding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Tau filament formation in transgenic mice expressing P301L tau.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

beta-Amyloid induces paired helical filament-like tau filaments in tissue culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Abnormally phosphorylated tau in SY5Y human neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Tau protein is hyperphosphorylated in a site-specific manner in apoptotic neuronal PC12 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

In vitro model of neurotoxicity of Abeta 1-42 and neuroprotection by a pentapeptide: irreversible events during the first hour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Okadaic acid disrupts clusters of synaptic vesicles in frog motor nerve terminals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Early phase of amyloid beta42-induced cytotoxicity in neuronal cells is associated with vacuole formation and enhancement of exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Shift from fetal-type to Alzheimer-type phosphorylated Tau proteins in SKNSH-SY 5Y cells treated with okadaic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Monoclonal antibodies with selective specificity for Alzheimer Tau are directed against phosphatase-sensitive epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Co-localization of amyloid beta and tau pathology in Alzheimer's disease synaptosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Epitope mapping of monoclonal antibodies to the paired helical filaments of Alzheimer's disease: identification of phosphorylation sites in tau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Amyloid beta peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

PP1 inhibition by Abeta peptide as a potential pathological mechanism in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Simultaneous evanescent wave imaging of insulin vesicle membrane and cargo during a single exocytotic event

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Pseudophosphorylation of tau at serine 422 inhibits caspase cleavage: in vitro evidence and implications for tangle formation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Tau protein isoforms, phosphorylation and role in neurodegenerative disorders11These authors contributed equally to this work

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11010-010-0671-7

Filamentous nerve cell inclusions in neurodegenerative diseases

21 January 2018

1 reference

12 December 2020

The phosphorylation state of tau in the developing rat brain is regulated by phosphoprotein phosphatases.

1 reference

12 December 2020

Protein sequence and mass spectrometric analyses of tau in the Alzheimer's disease brain

1 reference

12 December 2020

Biochemical and molecular characterization of neurofibrillary degeneration in frontotemporal dementias

1 reference

12 December 2020

Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria.

1 reference

12 December 2020

Clinico-pathologic studies in dementia: nondemented subjects with pathologically confirmed Alzheimer's disease

1 reference

12 December 2020

10.1007/S11010-010-0671-7

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

21113648